Genetics
Recent studies in mouse models based on UBE3A gene replacement or reactivation in neurons hold great therapeutic potential, including for the treatment of epilepsy.
Genetics
Epilepsy study calls for 2-year checks to keep pace with scientific advances.
Discover the latest about what's happening at CURE and in our community in the November 2018 CURE Update from Chief Scientific Officer, Laura Lubbers!
Pediatric Epilepsy
Resective surgery is a viable option in some patients to treat seizures that are associated with Lennox-Gastaut syndrome, with a high probability of seizure control and better adaptive function.
The disruption of Dnm1 leads to seizure like-activity in zebrafish, suggesting that this is a promising model system.
Virginia Tech is launching a $2.6 million study, funded by CURE, to determine if traumatic brain injuries can cause changes within the brain that lead to epilepsy.
Pediatric Epilepsy
Clinicians developed and validated a model to help determine the risk of epilepsy in children who have one or more paroxysmal events.
The FDA approved SYMPAZAN™ (clobazam) oral film for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.
Epidiolex, the first cannabis-based medication approved by the US Food and Drug Administration, is now available by prescription in all 50 states.
